Fentanyl: trend-spotting overview and focus on deaths. Jane Mounteney EMCDDA

Size: px
Start display at page:

Download "Fentanyl: trend-spotting overview and focus on deaths. Jane Mounteney EMCDDA"

Transcription

1 Fentanyl: trend-spotting overview and focus on deaths Jane Mounteney EMCDDA

2 Trendspotter - concept In depth information gathering On subject of concern, uncertainty One off and ad hoc Rapid reporting 2

3 Trendspotter methods Multi source, multi-method, multi-disciplinary, triangulation: Literature review Routine data collection Electronic survey MEETING Expert presentations Work groups Analysis 3

4 2012 Fentanyl trendspotter study Aim To increase our understanding of the illicit use and availability of fentanyl in Europe, in particular: extent and patterns of illicit fentanyl use illicit production and diversion harms and deaths linked with fentanyl use responses 4

5 Impetus for the study EWS signals - misuse of synthetic opioids on the rise Fentanyl the most potent, dangerous Estonia - long term reporting of serious problems, deaths Accumulation of reports - Slovakia & Bulgaria, linked with heroin shortages Outbreaks in Germany, Sweden 5

6 Sources of fentanyl(s) supply Illicitly manufactured fentanyls - limited to fentanyl and TMF Misuse of fentanyl-containing medicines, mainly transdermal patches Medical sources diverse - theft & diversion, overprescribing, doctor shopping, waste products. Internet 6

7 Seizures of medicinal fentanyl in last 3 years Seizures of illicitly manufactured fentanyls in last 3 years 7

8 Diverse epidemiology/country situations Some countries - no data One off events e.g. Portugal Continuous low level noise Outbreaks - linked with ODs and deaths - different types (prescribing, new lab) Endemic, established problem (Estonia) 8

9 DRD data key to understanding the epidemiology 40 1 death Epidemic curves Number of cases 25 20???? Age/gender pyramids Age band Female Male Deaths by fentanyl type Number of deaths Deaths in 2011 by type of fentanyl Number Fentanyl 3 methylfentanyl, fentanyl 3 methylfentanyl Geographical distribution Month 16 Numbers of cases 12 8 Viljandi Tallinn Sillamäe Narva Lääne-Viru county Kohtla-Järve Jõhvi Ida-Viru county Harjumaa Months 9

10 Deaths related to fentanyl different epidemic curves 40 Number of cases death 20???? 15 5 Estonia (650) Number of cases 9 1 death Sweden (?59) death Source 2011 Police data Source Special register. Communication Head of NFP 38 cases in 2011, 21 cases in 20 - tbc N u m b e r o f c a s e s Germany (160) 1/4 of all DRD screnned. 5% positive 2/3 of all DRD screnned. 11% positive Progressive improvement in screening for fentanyl : 28% of DRD cases screened and Source:Kipke Poster 2011 and communication 2009-: 65% of DRD cases screened UK (50) 1 death Source:Np-SAD J. Corkery communication

11 United Kingdom A g e b an d >= Female Male Number of deaths reported Age band Germany >= Female Male Age band Estonia Number of deaths reported Female Male Number of deaths 11

12 Estonia share of fentanyl / 3MF Deaths in 2011 by type of fentanyl Number 8 Fentanyl 3 methylfentanyl, fentanyl 3 methylfentanyl Month 12

13 On going risks & considerations Threat from continued heroin shortages? Role of pharmaceutical industry in promotion of patches? Importance of not hindering appropriate medical pain management Economic crisis - palliative care increasingly likely to be outside hospital settings Environmental health risk - need for safe waste disposal 13

14 Fentanyl a microcosm of complex modern day drug market Symptomatic of Europe s growing synthetic opioid misuse problem Illicit component Misuse/diversion of medicines Designer drug, internet availability? and environmental health implications 14

15 Fentanyls 2013 update Multiple reports of fentanyls (ODs & seizures) from Canada, US, Australia, EU.. Fentanyls emerging as NPS e.g. Carfentanyl - EWS alert Feb g seized in Latvia (not under international control) Carfentanyl is 4000x more potent than morphine 15

16 Fentanyls DRD updates We invite and welcome comments from experts on study and recent data 16

17 Update 2013 reports Estonia 40 1 death 35 Sweden: Toxicological analyses at the National Board of Forensic Medicine: positive for tramadol Number of cases 20???? UK: np-sad data

Improving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis

Improving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis Improving our capacity of identification and reporting on emerging trends New methods and new areas of analysis Monitoring challenges Rapidly changing, globalised drug market Growth of online and virtual

More information

Tramadol-related deaths

Tramadol-related deaths Tramadol-related deaths 216 Survey overview European joint DRD expert meeting Lisbon, 29-3 September 216 Isabelle Giraudon, Federica Mathis, Klaudia Palczak Paralel workshop Opioids, medicines and focus

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

Expert Peer Review for Carfentanil

Expert Peer Review for Carfentanil Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017 Expert Peer Review for Carfentanil 1. Comments based on the review report a. Evidence on dependence and abuse potential

More information

NPS use, harms and health responses to NPS in Europe: findings form multi-method studies

NPS use, harms and health responses to NPS in Europe: findings form multi-method studies NPS use, harms and health responses to NPS in Europe: findings form multi-method studies Alessandro Pirona Brussels, September 2017 NPS & public health responses Set the scene by providing a brief update

More information

NSPs in Estonia: current situation and future challenges

NSPs in Estonia: current situation and future challenges NSPs in Estonia: current situation and future challenges Aljona Kurbatova National Institute for Health Development Riga, 25.10.2010 1 Background First NSP project was launched in May 1997 needle and syringe

More information

2018 APM Winter Meeting San Antonio, TX

2018 APM Winter Meeting San Antonio, TX Moving target: The opioid crisis in the era of illicit fentanyl Alexander Y. Walley, MD, MSc Associate Professor of Medicine, BUSM Director, Addiction Medicine Fellowship, BMC Medical Director, Opioid

More information

Fentanyls. Reference materials LGC Quality ISO 9001 ISO/IEC ISO Guide 34 GMP/GLP ISO ISO/IEC 17043

Fentanyls. Reference materials LGC Quality ISO 9001 ISO/IEC ISO Guide 34 GMP/GLP ISO ISO/IEC 17043 Reference materials 2017 LGC Quality ISO 9001 ISO/IEC 17025 ISO Guide 34 GMP/GLP ISO 13485 ISO/IEC 17043 Science for a safer world The emergence of fentanyls as drugs of abuse represents the greatest challenge

More information

Opioid Overdose in Oregon Report to the Legislature

Opioid Overdose in Oregon Report to the Legislature SEPTEMBER 2018 Opioid Overdose in Oregon Report to the Legislature This report summarizes the burden of opioid overdose among Oregonians as required by ORS 432.141. It describes Oregon s progress in reducing

More information

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

EMCDDA-update HIV/HCV among people who inject drugs: situation and response EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis

More information

The issues facing Europe

The issues facing Europe The issues facing Europe An overview Andrew Cunningham Supply reduction and New Drugs unit 28 May 2015 European Drug Report 2015 https://youtu.be/vzzyp3k6psk 2 Opiates (heroin) Europe s main drug issue

More information

Annual report 2012: the state of the drugs problem in Europe

Annual report 2012: the state of the drugs problem in Europe Annual report 2012: the state of the drugs problem in Europe Ilze Jekabsone, MD, MPH Reitox and international cooperation unit 14 December 2012 2 Setting the scene After 30+ years with heroin centre stage

More information

Fentanils in Europe: perspective from the EU EWS

Fentanils in Europe: perspective from the EU EWS Fentanils in Europe: perspective from the EU EWS Rita Jorge Lisboa, 19 September 2017 DRD Expert Meeting This presentation The EU EWS The fentanils family Emergence of fentanils in the EU Outbreaks Public

More information

Annual report 2009: the state of the drugs problem in Europe

Annual report 2009: the state of the drugs problem in Europe Annual report 2009: the state of the drugs problem in Europe Alessandro Pirona, Rome 05/11/2009 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Established: 1993 Seat: Lisbon Staff: 100

More information

Click for Support REALized

Click for Support REALized Click for Support REALized Newsletter #1: July 2017 1. Introduction In January 2017, the 2-year Click for Support REALized project (co-funded by the European Commission) with thirteen partner organisations

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

EWS manual information flow alert database on NPS

EWS manual information flow alert database on NPS EWS manual information flow alert database on NPS 2nd Annual meeting COPOLAD II: National drugs observatories Lisbon, 13-17 November 2017 Flow of information Principal objective of EWS collect and disseminate

More information

Viewpoints on future dissemination of take-home naloxone: opportunities and challenges

Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Dagmar Hedrich & Isabelle Giraudon, EMCDDA Bergen, 1 September 2015 OVERDOSEKONFERANSEN 2015 ThINCBergen2015: The

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14

More information

Fentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar. July-16-18

Fentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar. July-16-18 Fentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar Opioid Situation-How we got here 2012 Oxycontin moves to the tamper proof version OxyNeo (Purdue Pharma) 2012/2013 Patch diversion and

More information

The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe

The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe Rachel Christie, PhD NDEWS webinar: Examining Global Drug Early Warning Systems, Part 4: Monitoring Drug Trends

More information

Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E.

Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E. Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E. Buttram, PhD Nova Southeastern University Center for Applied Research on

More information

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Epidemiology of non medical use of prescription drugs Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Monitoring of the drug use situation: Annual reports questionnaire

More information

Conventional and emerging drugs of abuse: the current situation

Conventional and emerging drugs of abuse: the current situation Conventional and emerging drugs of abuse: the current situation NEW PSYCHOACTIVE SUBSTANCES -THE HIGHS AND LOWS Maritim Hotel, Munich, 12-13 November 2015 Michael Uhl Director of Chemistry Unit Bavarian

More information

RADARS System International Pre-Symposium 11 May Global Insights in Prescription Drug Misuse

RADARS System International Pre-Symposium 11 May Global Insights in Prescription Drug Misuse RADARS System International Pre-Symposium 11 May 2017 Global Insights in Prescription Drug Misuse WELCOME 2 The Global Mosaic: RADARS System International Program Updates Jody L. Green, PhD, CCRP Director

More information

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith There is something in the heroin: responding to a rise in drug related deaths and the emergence of fentanyl and carfentanil in a local illicit drug market Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony

More information

New trends in harm reduction in Europe: progress made challenges ahead

New trends in harm reduction in Europe: progress made challenges ahead New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm

More information

Present and potential perspectives for information on alcohol use in the EU

Present and potential perspectives for information on alcohol use in the EU EMCDDA Present and potential perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 7-8 June 2016 CNAPA meeting Topics in this presentation 1.- EMCDDA overview and its work on

More information

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term

More information

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration Alexander Grabenhofer-Eggerth TDI expert meeting - Lisbon,

More information

The Information Professionals role in monitoring the international proliferation of novel psychoactive substances

The Information Professionals role in monitoring the international proliferation of novel psychoactive substances The Information Professionals role in monitoring the international proliferation of novel psychoactive substances Chad Dubeau, MLIS Matthew Young, PhD Although the proliferation of novel psychoactive substances

More information

Trends in injecting drug use in Europe

Trends in injecting drug use in Europe Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information

More information

(U) Cocaine/Fentanyl Combination in Pennsylvania

(U) Cocaine/Fentanyl Combination in Pennsylvania (U) Cocaine/ Combination in Pennsylvania (U) This DEA Bulletin is based on preliminary reporting and may be subject to updating as additional information becomes available. DEA-PHL-BUL-059-18 JANUARY 2018

More information

Pharmaceutical Fentanyl s (PF) Role in Fentanyl- related Overdose Deaths

Pharmaceutical Fentanyl s (PF) Role in Fentanyl- related Overdose Deaths Pharmaceutical Fentanyl s (PF) Role in Fentanyl- related Overdose Deaths Paper presented at the 2018 annual meetings of the American Public Health Association, San Diego, CA Session 5061.0: Impact of fentanyl

More information

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem Objectives Discuss the recent spread of opioid misuse Discuss the rise of the current opioid crisis, a national addiction/overdose problem Includes medical and illicit opioids Objectives Discuss the dangers

More information

DRUG OVERDOSE DEATHS ANALYSIS

DRUG OVERDOSE DEATHS ANALYSIS Overview CUYAHOGA COUNTY MEDICAL EXAMINER DRUG OVERDOSE DEATHS ANALYSIS Analysis of Fentanyl-Related Overdose Deaths in Cleveland/Cuyahoga County, Ohio in 2014 April 2015 The Cuyahoga County Medical Examiner

More information

The Opioid Epidemic: Overdose Data in NYC

The Opioid Epidemic: Overdose Data in NYC The Opioid Epidemic: Overdose Data in NYC Sindhu Shamasunder, MPH Bureau of Alcohol and Drug Use Prevention, Care and Treatment NYC Department of Health and Mental Hygiene The burden of drug overdose Nationally,

More information

Project Meeting Prague

Project Meeting Prague Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated

More information

Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe

Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe No conflict of interest Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe Ana Gallegos 24 September 2015 Lisbon Addictions Conference 2015 Paper session

More information

Drug Trends and Trafficking in Montana and Beyond

Drug Trends and Trafficking in Montana and Beyond Drug Trends and Trafficking in Montana and Beyond DRUG ENFORCEMENT ADMINISTRATION Travis Birney Special Agent Billings Resident Office Travis.C.Birney@usdoj.gov Office: 406-655-2914 Cell: 406-208-9242

More information

Drug Threat Summaries of Designated Areas

Drug Threat Summaries of Designated Areas Drug Threat Summaries of Designated Areas Oregon-Idaho HIDTA Program Oregon-Idaho HIDTA Investigative Support Center November 217 Page Intentionally Left Blank Prepared by the Oregon-Idaho Investigative

More information

Developing a drug monitoring system for New Zealand: IDMS

Developing a drug monitoring system for New Zealand: IDMS Developing a drug monitoring system for New Zealand: IDMS 2006-2016 NDEWS webinar "Examining Global Drug Early Warning Systems 26 th September 2017 Chris Wilkins SHORE & Whariki Research Centre College

More information

Intertwined Epidemics: Opioid and Heroin-related Overdose

Intertwined Epidemics: Opioid and Heroin-related Overdose Intertwined Epidemics: Opioid and Heroin-related Overdose Dan Ciccarone, MD, MPH Professor, Family and Community Medicine University of California, San Francisco Sarah Mars, PhD University of California,

More information

Opioids Are Seniors at Risk? (April 26, 2018)

Opioids Are Seniors at Risk? (April 26, 2018) Opioids Are Seniors at Risk? (April 26, 2018) Seniors are living longer and, with age, they become vulnerable to health challenges and the pain that may accompany them. Thus, it is perhaps not surprising

More information

EMCDDA trend report for the evaluation of the EU drugs strategy

EMCDDA trend report for the evaluation of the EU drugs strategy EMCDDA trend report for the evaluation of the 2005 12 EU drugs strategy Contents Executive summary...4 Drug use and drug-related problems...4 Drug supply and new drugs...6 Drug policies...7 Demand reduction...8

More information

FENTANYL: FACT AND FICTION. Catriona Remocker, Centre for Addictions Research of BC Dan Reist, Centre for Addictions Research of BC

FENTANYL: FACT AND FICTION. Catriona Remocker, Centre for Addictions Research of BC Dan Reist, Centre for Addictions Research of BC FENTANYL: FACT AND FICTION Catriona Remocker, Centre for Addictions Research of BC Dan Reist, Centre for Addictions Research of BC What is an OUTBREAK and what is an EPIDEMIC? Why is the opioid crisis

More information

Insights into shared and specific features of intensive drug use in Europe

Insights into shared and specific features of intensive drug use in Europe DANICA KLEMPOVA & FRANK ZOBEL Overview Insights into shared and specific features of intensive drug use in Europe Introduction Describing the European Union drug situation has always been a challenge for

More information

Drug Trend Bulletin - Issue 15 June 2017.

Drug Trend Bulletin - Issue 15 June 2017. - Issue 15 June 2017. New legislation changes. On the 31 st May 2017, the Misuse of Drugs Act 1971 will be updated to regulate the drugs shown in the table below. Misuse of Drugs 1971 - Update 31 st May

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides

More information

Prof. Dr Heino Stöver Faculty of Health and Social Work University of Applied Sciences Frankfurt, Germany

Prof. Dr Heino Stöver Faculty of Health and Social Work University of Applied Sciences Frankfurt, Germany Prof. Dr Heino Stöver Faculty of Health and Social Work University of Applied Sciences Frankfurt, Germany The Treatment Demand Indicator (TDI) 12th Annual Expert Meeting 2012 Lisbon (EMCDDA), Portugal

More information

FACT SHEET. A selection of internet-based information. Methedrone (bk-pmma)

FACT SHEET. A selection of internet-based information. Methedrone (bk-pmma) FACT SHEET A selection of internet-based information Methedrone (bk-pmma) Scientific Institute of Public Health Drugs and Illegal Substances Program National Focal Point on Drugs Juliette Wytsmanstreet

More information

Proposal for a COUNCIL IMPLEMENTING DECISION

Proposal for a COUNCIL IMPLEMENTING DECISION EUROPEAN COMMISSION Brussels, 18.12.2017 COM(2017) 765 final 2017/0345 (NLE) Proposal for a COUNCIL IMPLEMENTING DECISION on subjecting the new psychoactive substance methyl 1-(2-phenylethyl)-4- [phenyl(propanoyl)amino]piperidine-4-carboxylate

More information

Taking Stock of the 2009 PoA Research and Trend Analysis Branch

Taking Stock of the 2009 PoA Research and Trend Analysis Branch Taking Stock of the 2009 PoA Research and Trend Analysis Branch Eliminate or reduce significantly and measurably: The five targets Illicit cultivation of opium, coca, cannabis Illicit demand of drugs and

More information

Officer Al Fear Eastern Iowa Heroin Initiative Cedar Rapids Police Department U.S. Attorney s Office NDIA

Officer Al Fear Eastern Iowa Heroin Initiative Cedar Rapids Police Department U.S. Attorney s Office NDIA Officer Al Fear Eastern Iowa Heroin Initiative Cedar Rapids Police Department U.S. Attorney s Office NDIA Angie Asa-Lovstad, MS, CTF, CPS Co-Director, Alliance of Coalitions for Change (AC4C) Certified

More information

EWS in the frame of the Joint Action on NSD and draft Council Decision on new psychoactive substances

EWS in the frame of the Joint Action on NSD and draft Council Decision on new psychoactive substances EWS in the frame of the Joint Action on NSD and draft Council Decision on new psychoactive substances Roumen Sedefov, Budapest, March 2005 Synthetic drugs overview 1 EU is concerned because: widely consumed

More information

MODUS OPERANDI FENTANYL. Control No.: P-693/

MODUS OPERANDI FENTANYL. Control No.: P-693/ Control No.: P-693/09-2017 Requesting country: The United States of America File No.: 2017/202335-1 Date of publication: 13/09/2017 MODUS OPERANDI FENTANYL RISE IN USE, OVERDOSE, AND EXPOSURE TO AN OPIOID

More information

ESTONIA DRUG SITUATION 2002

ESTONIA DRUG SITUATION 2002 Institute of Experimental and Clinical Medicine Estonian Drug Monitoring Centre Estonian National Focal Point ESTONIA DRUG SITUATION 2002 Katri Abel Ave Talu Aljona Kurbatova Andri Ahven Gleb Denissov

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-FIRST REGULAR SESSION April 24-26, 2017 Washington, D.C. OEA/Ser.L/XIV.2.61 CICAD/doc.2299/17 21 April 2017 Original: English CANADA S OPIOID

More information

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements found in the opium poppy plant. These drugs are

More information

Opioid Use and Other Trends

Opioid Use and Other Trends Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current

More information

Understanding the Opioid Crisis: What s at the Heart of the Matter?

Understanding the Opioid Crisis: What s at the Heart of the Matter? National Center for Injury Prevention and Control Understanding the Opioid Crisis: What s at the Heart of the Matter? Sara Patterson Associate Director for Policy National Center for Injury Prevention

More information

Rising Threats in the Nation s Drug Epidemic

Rising Threats in the Nation s Drug Epidemic WiFi: CWAGNM No Password Rising Threats in the Nation s Drug Epidemic Michael E. Prevoznik Senior Vice President and General Counsel Conference of Western Attorneys General Annual Meeting July 2018 2 An

More information

Access to needle and syringe exchange services in Estonia

Access to needle and syringe exchange services in Estonia Access to needle and syringe exchange services in Estonia presented by Aljona Kurbatova prepared by Aire Trummal (initially prepared for the workshop How do we know what works? (BZgA, WHO), Berlin, 23.10.2008)

More information

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Hepatitis A Key facts In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed. The

More information

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging

More information

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

More information

Drug trafficking via the darknet. Chloé Carpentier Chief, Drug Research Section 23 October 2018

Drug trafficking via the darknet. Chloé Carpentier Chief, Drug Research Section 23 October 2018 Drug trafficking via the darknet Chloé Carpentier Chief, Drug Research Section 23 October The darknet Identity of darknet users is hidden (TOR - The Onion Router ) Trading platforms where drugs can be

More information

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School

More information

2018 Medical Marvels Research Competition A research competition for students in grades 9 and 10

2018 Medical Marvels Research Competition A research competition for students in grades 9 and 10 2018 Medical Marvels Research Competition A research competition for students in grades 9 and 10 Sponsored by the Feinstein Institute for Medical Research and the Center for Workforce Readiness The Northwell

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D 1 INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-SECOND REGULAR SESSION November 28-30, 2012 San José, Costa Rica OEA/Ser.L/XIV.2.52 CICAD/doc.1988/12

More information

TITLE SECOND LINE SPEAKER

TITLE SECOND LINE SPEAKER WENNBERG INTERNATIONAL COLLABORATIVE SPRING POLICY MEETING 2018 Inter-regional Variation In Opioid Prescription Patterns In Emilia-romagna And Tuscany TITLE STYLE MARIA PIA FANTINI, DARIO TEDESCO, BRUNA

More information

Illicit Opioid and Methamphetamine Trends in Maine

Illicit Opioid and Methamphetamine Trends in Maine Illicit Opioid and Methamphetamine Trends in Maine Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine Objectives Provide an overview of the illicit opioid crisis in Maine, focusing

More information

Alcohol Prevention Day

Alcohol Prevention Day Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in

More information

Estonia Estonia Drug Report 2018

Estonia Estonia Drug Report 2018 Estonia Estonia Drug Report 218 This report presents the top-level overview of the drug phenomenon in Estonia, covering drug supply, use and public health problems as well as drug policy and responses.

More information

Acute Drug Toxicity Data

Acute Drug Toxicity Data Acute Drug Toxicity Data Recreational drug use is common Systematic data is available on: Prevalence of drug use Drug seizures Use of treatment agencies for problem drug use Drug-related fatalities There

More information

Understanding the Opiate Epidemic

Understanding the Opiate Epidemic Understanding the Opiate Epidemic An opiate is a narcotic analgesic that depresses the central nervous system. Natural opiates are derived from the poppy plant. Synthetic opiates are manufactured drugs

More information

HEROIN OVERDOSES IN JUPITER

HEROIN OVERDOSES IN JUPITER HEROIN OVERDOSES IN JUPITER PRELMINARY ANALYSIS 5/2/2017 1 BACKGROUND Opioid Pain reducing medication to include oxycodone, hydrocodone, morphine, as well as heroin. These drugs can become addictive and

More information

Global drug trends and sustainable development

Global drug trends and sustainable development Lau Global drug trends and sustainable development Chloé Carpentier Chief, Drug Research Section UNODC Göteborg, 15 November 2017 Global trends in estimated number of drug users and people with drug user

More information

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND ERKKI VUORI 12.-13.11.2012 HJELT INSTITUUTTI OIKEUSLÄÄKETIETEEN OSASTO FINLAND IS AN IDEAL COUNTRY FOR POST- MORTEM TOXICOLOGICAL INVESTIGATIONS High autopsy

More information

Launch of the INCB Annual Reports 2015

Launch of the INCB Annual Reports 2015 Launch of the INCB Annual Reports 2015 Werner Sipp, INCB President 2 March 2016 1 The 3 Reports 2 Mandate of INCB Promote and monitor compliance with the 3 international drug control conventions by: Annual

More information

Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS)

Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS) Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS) Grund, Jean-Paul Vavrinčíková, Lenka Janíková, Barbara Fidesová, Hana Health responses to NPS EMCDDA, Lisboa. 28-10-2015

More information

Opioid education programs and nasal naloxone rescue kits

Opioid education programs and nasal naloxone rescue kits Opioid education programs and nasal naloxone rescue kits Arne Skulberg PhD student NTNU Consultant Anaesthetist, Oslo Epidemiology Europe 2 Epidemiology US 200 % increase in opioid overdoses since 2000.

More information

Fentanyl, Opioid Overdose and Naloxone

Fentanyl, Opioid Overdose and Naloxone Fentanyl, Opioid Overdose and Naloxone Opioid Agonist Therapy Conference Saskatoon, SK April, 2016 Declaration No conflict of interest. Consultant in Addiction Medicine, SHR. Chair, College of Physicians

More information

DRUG - RELATED DEATH

DRUG - RELATED DEATH DRUG - RELATED DEATH Lithuania EVELINA PRIDOTKIENĖ D R U G, TA B A C C O A N D A L C O H O L C O N T R O L D E PA R T M E N T H E A D OF N AT I O N A L F O C A L P O I N T Background: Since 2010 data on

More information

Thermo Scientific TruNarc Handheld Narcotics Analyzer

Thermo Scientific TruNarc Handheld Narcotics Analyzer Thermo Scientific TruNarc Handheld Narcotics Analyzer Field-based presumptive narcotics, precursor and cutting agent testing The TruNarc Handheld Narcotics Analyzer Tests for over 400 substances, including

More information

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

Highly pathogenic avian influenza The Epidemic Regionalisation in the European Union Highly pathogenic avian influenza "The 2016-2017 Epidemic" Regionalisation in the European Union Andrea Gavinelli, Head of Unit G3 Official controls and eradication of diseases in animals European Commission

More information

Overview of the Activities of Estonian Pharmacies

Overview of the Activities of Estonian Pharmacies No of inhabitants Overview of the Activities of Estonian Pharmacies Number of Pharmacies There are three types of pharmacies in Estonia: general pharmacies, veterinary pharmacies and hospital pharmacies.

More information

EMCDDA Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA

EMCDDA Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA EMCDDA Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA In accordance with Article 10 of Council Decision 2005/387/JHA on the information exchange, risk-assessment and

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

More information

Opioid epidemic and PEHP

Opioid epidemic and PEHP Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe

More information

Professor Paul I Dargan

Professor Paul I Dargan General Overview of the Euro-DEN Dataset: 5529 presentations with acute drug toxicity in 16 sentinel European centres Professor Paul I Dargan Guy s s and St Thomas NHS Foundation Trust and King s s College

More information

Syntetic opioids and NPS. Håkan Leifman Director

Syntetic opioids and NPS. Håkan Leifman Director Syntetic opioids and NPS Håkan Leifman Director Cannabis totalt Marijuana Hasch Spice el. likn. Ecstasy Sedatives Cocaine Amphetamine Don't know Others Heroine GHB No answer Experiences of different narcotic

More information

MARKET NEWS for pig meat

MARKET NEWS for pig meat MARKET NEWS for pig meat Market analysis 26 November 2018 Week 48 MARKET SITUATION Europe: Trading in legs is at slightly increasing or unchanged prices this week. Trading in other cuts is at unchanged

More information

World Drug Report 2017

World Drug Report 2017 World Drug Report 2017 DEMAND Global trends in estimated number of drug users and people with drug user disorders, 2006-2015 Global trends in the estimated prevalence of drug use and prevalence of people

More information

Supervised Injection Services: Evidence and Practice

Supervised Injection Services: Evidence and Practice January 30 th, 2018 12:00 p.m. 1 p.m. (EDT) Supervised Injection Services: Evidence and Practice Mary Clare Kennedy, MA, PhD (cand) - University of British Columbia, BC Centre on Substance Use Tim Gauthier,

More information

YOUTH OPIOID ABUSE PREVENTION TOOLKIT

YOUTH OPIOID ABUSE PREVENTION TOOLKIT YOUTH OPIOID ABUSE PREVENTION TOOLKIT President Trump, the First Lady and the entire Trump Administration is committed to combatting the opioid crisis. The youth opioid abuse prevention campaign will be

More information

EXPANDED MAINE DRUG DEATH REPORT FOR 2016 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview

EXPANDED MAINE DRUG DEATH REPORT FOR 2016 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview EXPANDED MAINE DRUG DEATH REPORT FOR 216 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine This report, funded by the Maine Office of Attorney General, provides a summary of

More information

Community Opioid Load: Concept to Action in Kingston-KFLA

Community Opioid Load: Concept to Action in Kingston-KFLA Community Opioid Load: Concept to Action in Kingston-KFLA Dr Kieran Moore CCFP (EM ) FCFP FRCPC MPH MSc (DM ) Professor of Emergency and Family Medicine Associate Medical Officer of Health, KFLA, Program

More information